Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Pharmacotherapy. 2013 Jul 17;33(11):1156–1164. doi: 10.1002/phar.1329

Table 2.

Characteristics of patients enrolled

Characteristic Total n=80
Age (years) 50 ± 18
Female sex 43 (54)
Self-reported race/ethnicity
 African American 45 (56)
 European 13 (16.5)
 Hispanic 13 (16.5)
 Other 9 (11)
Warfarin indication
 Deep vein thrombosis 25 (31)
 Pulmonary embolism 20 (25)
 Atrial fibrillation 12 (15)
 VTE prophylaxis after major orthopedic surgery 11 (14)
 Other 12 (15)
Genotype
VKORC1 -1639G>A
  AA 8 (10)
  AG 21 (26)
  GG 51 (64)
CYP2C9
  *1/*1 68 (85)
  *1/*2 10 (13)
  *1/*3 1 (1)
  *2/*2 1 (1)
CYP4F2 V433M
  VV 56 (70)
  VM 21 (26)
  MM 3 (4)